10 Federal Raises $80 Million in Q3 2023, Aims for $100 Million Fundraising Goal
Raleigh-Durham News

10 Federal Raises $80 Million in Q3 2023, Aims for $100 Million Fundraising Goal

Alcove Team | 10/9/23
Local company 10 Federal has announced raising $80 million in the third quarter of 2023, bringing their total funds raised this year to $80 million out of their goal of $100 million.
Alcove RDU Market Roundup 10/06/2023
Featured listings

Alcove RDU Market Roundup 10/06/2023

Alcove Team | 10/6/23
The RDU real estate market is showing significant activity this fall. This update provides insights into new listings and recent sales in the area, coupled with exciting regional news. Here's what's happening in the Raleigh-Durham market:
Toyota Begins Hiring for New Battery Manufacturing Plant in North Carolina
Raleigh-Durham News

Toyota Begins Hiring for New Battery Manufacturing Plant in North Carolina

Alcove Team | 10/6/23
Toyota has started the hiring process for its new battery manufacturing plant in Randolph County, North Carolina, with over 100 positions available.
North Carolina Land and Water Fund Awards $45 Million for Conservation Projects
Raleigh-Durham News

North Carolina Land and Water Fund Awards $45 Million for Conservation Projects

Alcove Team | 10/5/23
The North Carolina Land and Water Fund has allocated $45 million to protect the state's land and water through various projects that will benefit the environment and the economy.
Alcove RTP Market Roundup 10/04/2023
Featured listings

Alcove RTP Market Roundup 10/04/2023

Alcove Team | 10/4/23
The RDU real estate market is showing significant activity this fall. This update provides insights into new listings and recent sales in the area, coupled with exciting regional news. Here's what's happening in the Raleigh-Durham market:
Atsena Therapeutics Raises $24.5M to Develop Gene Therapies for Inherited Blindness
Raleigh-Durham News

Atsena Therapeutics Raises $24.5M to Develop Gene Therapies for Inherited Blindness

Alcove Team | 10/4/23
Durham-based Atsena Therapeutics has secured $24.5 million in private investment to advance its gene therapy treatments for inherited blindness. The company aims to raise an additional $7.5 million.
. . .
. . .